Related Experiment Videos
Physicians, pharmacists and patients' compliance with chronic treatment in Bulgaria
1Faculty of Pharmacy, Department of Social Pharmacy, Medical University-Sofia, Sofia, Bulgaria. vpetkova@mbox.pharmfac.acad.bg
Purpose:
To study the patient-physician and patient-pharmacist interrelation in order to reveal the systematic factors that influence patients' compliance.
Methods:
Standard individual questionnaires were developed and used to assess compliance and non-compliance among different categories of patients suffering from chronic diseases.
Results:
There is a relatively good communication between the patients and the health-care givers but in order to improve compliance (adherence) further, this level of communication has to be improved. The main reasons for non-adherence were: the high cost of drugs, the complexity of the daily regimen, negligence, and distrust of treatment. Insufficient information in the patient information leaflet, together with an inappropriate drug formulation also appear to be important factors that cause non-compliance. This is especially so, when patients have to receive more than one drug, or medications in different dosage forms, and it is particularly marked when elderly people are involved.
Conclusion:
Despite the comparatively high level of compliance found in this study (50-92%), there are possibilities for individualization of treatment that merit attention in order that the level of compliance can be improved.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drug Therapy
Antianxiety Medications
Drug Dosing: Geriatric Patients
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Bioavailability Study Design: Healthy Subjects Versus Patients